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Maximal oxygen uptake ( _VO2max) is a measure of cardiorespiratory fitness often used to
monitor changes in fitness during and after treatment in cancer patients. There is, however,
limited knowledge in how criteria verifying _VO2max work for patients newly diagnosed with
cancer. Therefore, the aim of this study was to describe the prevalence of fulfillment of typi-
cal criteria verifying _VO2max and to investigate the associations between the criteria and the
test leader’s evaluation whether a test was performed “to exhaustion”. An additional aim
was to establish new cut-points within the associated criteria.
Methods
From the Phys-Can randomized controlled trial, 535 patients (59 ±12 years) newly diag-
nosed with breast (79%), prostate (17%) or colorectal cancer (4%) performed an incremen-
tal _VO2max test on a treadmill. The test was performed before starting (neo-)adjuvant
treatment and an exercise intervention. Fulfillment of different cut-points within typical crite-
ria verifying _VO2max was described. The dependent key variables included in the initial
bivariate analysis were achievement of a _VO2 plateau, peak values for maximal heart rate,
respiratory exchange ratio (RER), the patients’ rating of perceived exertion on Borg’s scale6-
20 and peak breathing frequency (fR). A receiver operating characteristic analysis was per-
formed to establish cut-points for variables associated with the test leader’s evaluation.
Last, a cross-validation of the cut-points found in the receiver operating characteristic analy-
sis was performed on a comparable sample of cancer patients (n = 80).
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Results
The criteria RERpeak (<0.001), Borg’s RPE (<0.001) and fR peak (p = 0.018) were associ-
ated with the test leader’s evaluation of whether a test was defined as “to exhaustion”. The
cut-points that best predicted the test leader’s evaluation were RER� 1.14, RPE� 18 and
fR� 40. Maximal heart rate and _VO2 plateau was not associated with the test leader’s
evaluation.
Conclusion
We recommend a focus on RER (in the range between�1.1 and�1.15) and RPE (�17 or
�18) in addition to the test leader’s evaluation. Additionally, a fR peak of�40 breaths/min
may be a cut-point to help the test leader evaluate the degree of exhaustion. However, more
research is needed to verify our findings, and to investigate how these criteria will work
within a population that are undergoing or finished with cancer treatment.
Introduction
A continuously increasing number of people are living with or have survived cancer [1], with
most new cases occurring in persons aged 50 years and older [2]. Importantly, although
improved treatment strategies have increased survival from cancer [3], most cancer treatments
are collectively accompanied with negative effects on healthy cells and tissues [4–6]. Low levels
of physical activity in people diagnosed with cancer [7], in combination with side effects from
treatments causing injuries to the cardiovascular and muscular system [6, 8–10], are potent
reasons for the clinically relevant impairments in cardiorespiratory fitness often observed in
cancer treated individuals [11–14].
Patients with cancer are recommended to be as physically active as their abilities and condi-
tions allow before, during and after cancer treatment [15, 16]. However, current exercise rec-
ommendations are rather general [17] and do not differ much for patients with cancer
compared with the healthy population [18]. Based on a lack of individually tailored physical
activity and exercise guidelines (e.g. frequency, intensity, type and time), second-generation
trials, where specific exercise prescriptions are being investigated, are needed [19]. To be able
to prescribe tailored exercise programs involving endurance training and to evaluate the effect
of exercise programs, valid measurements of cardiorespiratory fitness are fundamental. One
important challenge with maximal exercise tests in various patient groups, and older adults in
general, is whether tests are performed with maximal effort [20]. A consequence of using sub-
maximal test results is prescribing an exercise intensity that is too low. In addition, compari-
sons within (e.g. comparing different exercise intensities) and between studies is complicated
if we rely on biased data [21].
When measuring cardiorespiratory fitness, direct assessment of maximal oxygen uptake
( _VO2max) is acknowledged as the gold standard [22]. To ensure high validity and reliability of
a _VO2max test (i.e. results can be reproduced), accurate instruments and experienced person-
nel are important [23]. Different patients and healthy individuals have various levels of experi-
ence with exercise and subjective evaluations of their effort. Furthermore, among patients with
cancer, the heterogeneity may be even larger because they often are older [2], more unfit [11],
and may have comorbidities and side effects like fatigue or pain [4, 24, 25]. Therefore, when
assessing such a heterogenetic group of people, objective criteria to support the decision
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whether a patient with cancer has reached her/his maximal effort (verifying _VO2max) is
important [23].
The most widely used objective criteria, a plateau or levelling off in _VO2 with increasing
workload, has been extensively debated the last 20–30 years [26–31]. Variations in the number
of subjects attaining a _VO2 plateau are seen across studies [32], and secondary criteria are also
included when verifying _VO2max. The term _VO2peak (the highest value attained during exer-
cise [33]) is often used when involving exercise-naïve and/or clinical populations, as there is
an assumption that these persons seldom reach their highest physiologically attainable value
( _VO2max) [33]. In the literature, estimated peak heart rate (HR), peak respiratory exchange
ratio (RER), post exercise blood lactate (BLa-), and self-reported Rating of Perceived Exertion
(RPE) on Borg’s scale6-20 (or other scales), with a variety of cut-points, are reported as second-
ary criteria to verify _VO2max [34, 35]. How close these secondary criteria are associated with
_VO2max is not well validated. Because they all have pros and cons, the criteria and their cut-
points have been discussed in the literature [23, 34–36]. Furthermore, there is no consensus on
how to apply these criteria in various populations [23], but some suggestions have been made
for healthy athletes [34], healthy adult subjects between 20 and 85 years [37], and for over-
weight or obese adults [38, 39]. It might be challenging to apply these criteria in patients newly
diagnosed with cancer, and whether this population have the same physiological responses as
other populations is questionable. Nevertheless, the use of well-defined objective criteria in
testing newly diagnosed cancer patients is probably more important than in healthy popula-
tions because both the patient and test leader might be afraid of pushing towards maximal
effort. In addition to the often-used criteria, respiratory frequency (fR) has been suggested as a
valid variable for defining maximal effort [40], but to our knowledge, fR has not been used as a
criterion in _VO2max testing. Personal experiences from test-laboratories, in which fR has been
found to be useful as part of the effort-evaluation of people performing a _VO2max test, is
another rationale for adding this variable as a possible secondary criteria to verify _VO2max.
The test leader’s subjective evaluation whether a _VO2max test is performed to exhaustion is
important when considering the validity of _VO2max tests. Although evaluations of exertion
are based on predefined observations of body language and facial expressions, subjectivity is
still part of the test leader’s evaluation. How test personnel give instructions and how they ver-
bally encourage the person being tested are examples of possible biases that may affect the
validity of the test results [41]. Submaximal results may occur if the test leader is inexperienced
and is too “kind”; meaning that he/she does not motivate the person being tested enough, or
even terminates the test before a maximal effort has been reached, of various reasons (e.g. the
cancer diagnosis, comorbidities or age). Because of the aforementioned challenges of using the
_VO2 plateau in the evaluation of whether _VO2max is reached, we are dependent on experi-
enced and highly skilled test leaders who are able to evaluate whether a test is performed to
exhaustion. In the present study we chose this somewhat experimental approach, by giving the
test leaders’ evaluation of each _VO2max test a focus in the statistical analyses.
To our knowledge, there are only one published study where criteria verifying _VO2max
have been investigated within a population of patients diagnosed with cancer [42]. Schneider
et al. (2019) investigated how a supramaximal verification bout could be applied in relation to
feasibility and whether it could serve as a criterion when verifying _VO2max in survivors from
breast and prostate cancer [42]. The present study will support researchers and test leaders in
their decision concerning which secondary criteria to apply when evaluating future _VO2max
tests in newly diagnosed patients with breast, prostate or colorectal cancer. Presumably, not all
_VO2max tests in the future will be performed with an added verification bout. We present the
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fulfillment of a variety of criteria with different cut-points in our sample of patients. The pri-
mary objective was to determine which of the following variables; _VO2 plateau, RERpeak,
HRpeak, Borg’s RPE and fR peak, were associated with the test leader’s subjective evaluation of
whether the tests were defined as “to exhaustion”. In addition, cut-points within the associated
criteria were established. A second objective was to cross-validate these cut-points in a compa-
rable sample of patients with cancer.
Methods
Design and participants
The Phys-Can study was a multicenter randomized exercise trial with a descriptive observa-
tional study to be used for comparison [43]. For the intervention trial involving exercise, 600
adults (�18 years) recently diagnosed with either curable breast, prostate or colorectal cancer
scheduled to begin their (neo-)adjuvant therapy in Uppsala, Linköping and Malmö/Lund
(Sweden) were included. Exclusion criteria were stage IIIb-IV breast cancer, inability to per-
form basic activities of daily living, cognitive disorders, severe psychiatric disease or other dis-
abling conditions that might contraindicate high intensity exercise (e.g. severe heart failure,
severe chronic obstructive pulmonary disease or orthopaedic conditions), treatment for an
additional ongoing malignant disease, BMI<18.5 kg/m2 or pregnancy. This main study was
performed between March 2015 and November 2018. Full descriptions of the purpose, the
design and enrollment of the study are presented elsewhere [43]. The observational study
included 102 people following the same eligibility criteria and was performed between Septem-
ber 2014 and February 2015. All persons deemed as eligible by a physician/oncologist were
contacted by a member of the research staff who provided verbal and written information
about the study. Those who agreed to participate in the study gave their written informed con-
sent before baseline data collection. For the purpose of the present study and analyses per-
formed herein, 535 and 80 participants with _VO2max data at baseline (within the first week
after diagnosis) were included from the intervention- and observational study, respectively.
Three tests were excluded due to obvious technical issues (e.g. leakages from the face mask or
technical errors), but otherwise, all available baseline _VO2max tests were included in the
analyses.
The Phys-Can intervention study was approved by the Regional Ethical Review Board in
Uppsala, Sweden (Dnr 2014/249) and registered in ClinicalTrials.gov (TRN = NCT02473003,
October, 2014).
Cardiorespiratory fitness test
The participants were told not to eat, and drink anything other than water 2 hours before the
test. In addition, they were told not to perform strenuous physical activity on the test day or
the day before. At the test location, height and body mass were measured to the nearest 0.5 cm
and 0.1 kg, respectively, while wearing light clothes and no shoes [43].
Participants performed a continuously graded exercise test on a motorized treadmill (In
Uppsala; SportsArt Fitness Tr32, Washington, USA, in Lund; Rodby RL2500E, Vänge, Sweden
and in Linkøping; GE T2100, Helsinki, Finland (in 2015) and Rodby RL2000, Vänge, Sweden
(the remaining study period)) using a modified Balke protocol. Following a 5-min warm-up
with increasing workload, participants started at 4 km/h with an inclination of 2%. The incli-
nation increased with 2% each minute until reaching 12%, from which only the speed
increased 0.5 km/h per minute until exhaustion [43]. Gas exchange data were obtained breath-
by-breath, using the following different gas-analyzers: Uppsala; Viasys Vmax Encore, Care
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Fusion, San Diego, USA (accepted measurement errors for O2 analyzer: ±0.06–1%), Lund; Jae-
ger Oxycon Pro, CareFusion, Hoechberg, Germany (accepted measurement errors for O2 ana-
lyzer: ±0.05%) and in Linköping; Jaeger Oxycon Pro, CareFusion, Germany, Hoechberg (until
Dec 15) and Cosmed Quark CPET, Rome, Italy (accepted measurement errors for O2 analyzer:
±0.02%) in the remaining study period. The software used was: Uppsala; Vmax Encore and
Cardiosoft ECG, Version 6.7, San Diago, USA, Lund; LabManager, Jlab, CareFusion, version
5.31.0, Hoechberg, Germany and in Linköping; LabManager, Jlab, CareFusion, version
5.31.0.83, Hoechberg, Germany (in 2015) and Cosmed Quark PFT Ergo, Rome, Italy for the
remaining study period. To assess the rate of perceived exertion (RPE), Borg’s scale6-20 was
applied during and at the end of the _VO2max test [44]. Instructions in how to use this scale
were given before the test.
During the test, HR was measured using a Polar RS400 HR monitor in Uppsala, a Coded
Polar receiver 4208 (connected to Oxycon Pro) in Lund and a heart rate receiver in the EKG
equipment (GE Healthcare, CASE GE (connected to the Oxycon Pro) and a Cosmed SZ990
receiver (connected to the Cosmed Quark CPET) in Linköping. The peak average over 5 or 15
seconds was used when presenting HRpeak. Regarding _VO2, RER and fR, the highest 60 s
mean of the 10-, 15- or 30 s sampling averages (acquisition time differed between the tests/
labs) in the last part of the test was reported as the peak value. When describing fulfillment of
different percentages of predicted HR, the Tanaka equation, 208 − (0.7�age) was applied
because this has been found to be more valid than the often-used 220 − age HRmax equation
[45].
Detecting a plateau in oxygen uptake
A computer program was developed to detect whether a _VO2 plateau or leveling off occurred
during the test time. Using this program, each of the extracted excel files with the test results
were processed using an algorithm based on the definition of _VO2 plateau by Taylor and col-
leagues [46], where a change in _VO2 should be less than 150 mL from one minute to the next
(D _VO2 �150 ml/min). Additionally, the cut-points of�80 ml/min and�50 ml/min were
studied with similar definitions using the program. The highest average in _VO2 over 1 minute
was compared with the minute before or the minute after and whether _VO2 for these time
points differed�150 mL,�80 mL and�50 mL. Each of these three cut-points was investi-
gated to descriptively present the prevalence of fulfilling each cut point. In the logistic regres-
sion analysis, the cut-point of�150 ml/min was chosen to be included because this is believed
to fit best with our test-protocol which has very small expected _VO2 increments between each
stage [46].
Test leader evaluation
After completing the tests, the test leaders were instructed to report factors related to chal-
lenges that could affect test outcomes. Additionally, each test leader reported the evaluation of
every test with respect to whether the test was defined as “to exhaustion”. The evaluation was
based on the observed body language, such as unsteady walking/running, bending the upper
body (e.g. bending forward), facial expression showing exhaustion, hyperventilation and other
signs reflecting that a maximal effort had been given. All test leaders were instructed, certified
and followed up by the same person in the Phys-Can project group. A pilot-study was addi-
tionally conducted before the Phys-Can intervention study, where the predefined standards
and test protocols were proven by the test leaders (and with some cancer patients).
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Participant characteristics and questionnaires
Living situation, education, sick-leave, smoking status and diagnosis were retrieved through
questionnaires and medical journals. The Multidimensional Fatigue Inventory (MFI) [47] and
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire
for Cancer patients (EORTC QLQ C30) [48] were used to retrieve information about physical
fatigue, global health status and physical function.
Physical activity monitoring
The number of hours in moderate to vigorous intensity physical activity per day was retrieved
from the physical activity monitor SenseWear Armband Mini (BodyMedia Inc., Pittsburgh,
PA, USA). The activity monitor was delivered on the day the _VO2max test was performed.
Patients were instructed to wear it for 7 consecutive days, accepting at least 4 days of registra-
tion with at least 80% wearing time each day. Physical activity registrations above 3 metabolic
equivalents (METs) were defined as moderate to vigorous intensity physical activity [49].
Statistical analyses
Patient characteristics and results from the _VO2peak tests were presented as mean
values ± standard deviation (SD) and numbers with percentages. For descriptive purposes, the
mean _VO2peak within “fulfillment” and “not fulfillment” of a variety of criteria and cut-points
used in the literature were presented in a figure using GraphPad Prism version 7.00 for Win-
dows (GraphPad Software, La Jolla California, USA, www.graphpad.com).
To determine associations between the criteria variables and the test leader’s evaluation,
logistic regression analysis was performed using the Hosmer step-down procedure [50]. The
key dependent variables included in the initial bivariate analysis were achievement of a _VO2
plateau, HRpeak, RERpeak, Borgs’ RPEpeak and fRpeak. In addition, _VO2peak, diagnosis, age,
body mass and test time were included as adjusting variables. All variables significant at the
0.25 level were included in the final multivariate model. The odds ratios (ORs) and 95% confi-
dence intervals (95%CIs) were calculated for 0.10 units regarding RERpeak. To investigate col-
linearity and interaction, pairwise correlations were performed for all the five key dependent
variables in addition to _VO2peak and test time. Furthermore, a receiver operating characteris-
tic (ROC) analysis was performed to establish cut-points for variables associated with the test
leader’s evaluation. These cut-points represented the point where the sensitivity and specificity
were highest in correctly categorizing the test leader’s evaluation (“to exhaustion” or not).
Finally, a cross-validation of the cut-points found in the ROC analysis was performed on the
participants in the Phys-Can Cohort study, using a cross-table.
The analyses were performed using SPSS (IBM Corp. Released 2017. IBM SPSS Statistics
for Windows, Version 25.0, IBM Corp., Armonk, NY, USA) and Statistical Analysis System
(SAS version 9.1.3, SAS, North Carolina, USA). The level of statistical significance was set to
0.05.
Results
Baseline characteristics of the participants in the intervention and in the cohort study are pre-
sented in Table 1. The two samples were comparable in respect to all characteristics, where
mean age was 59 years and both samples included approximately 80% women with breast can-
cer, 15% men with prostate cancer and 4%–5% patients with colorectal cancer.
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Peak values and test duration from the cardiorespiratory fitness test are given in Table 2.
The prevalence of fulfilment of the three _VO2 plateau criteria cut-points in the intervention
and cohort study were: D _VO2 �150 ml/min; 90% and 86%, D _VO2 �80 ml/min; 63% and 65%,
and D _VO2 �50 ml/min; 45% and 53%.
Table 2. Peak values and test-duration from the _V_O2max-tests performed at baseline in the Phys-Can Interven-
tion study and the Phys-Can Cohort study, presented in mean (SD).
Phys-Can Intervention Phys-Can Cohort
_V_O2peak , ml/kg/min 29.8 (7.3) 29.2 (7.1)
HRpeak, beats/min 166 (19) 168 (19)
Predicted HRmax, %� 99 (9.2) 100 (9.6)
RERpeak, _VC_O2= _V
_O2 1.16 (0.10) 1.19 (0.11)
VEpeak, l/min 79 (20) 79 (19)
fR peak, breaths/min 40 (7.8) 41 (6.4)
Borg scale, RPE 6–20 17.9 (1.6) 17.0 (1.3)
Test-duration, min 9.9 (2.8) 9.4 (2.6)
Abbreviations: fR = respiratory frequency; RER = Respiratory Exchange Ratio; _VC_O2 = carbon dioxide production;
_V_O2 = oxygen uptake; VE = ventilation. �Percentage of predicted maximal heart rate, by the Tanaka formula.
https://doi.org/10.1371/journal.pone.0234507.t002
Table 1. Baseline characteristics of the participants in the Phys-Can Intervention study and the Phys-Can Cohort
study, presented in mean (SD) or numbers (%).
Phys-Can Intervention Phys-Can Cohort
Number of subjects, n 535 80
Age, years, mean (SD) 59 (12) 59 (11)
Female, n (%) 430 (80) 67 (84)
Living with a partner, n (%) 402 (75) 58 (73)
Completed University, n (%) 309 (58) 39 (49)
Sick-leave, n (%) 180 (34) 22 (28)
100% sick leave, n (%) 150 (28) 19 (24)
Obesity (BMI�30), n (%) 84 (16) 13 (16)
Current smoker, n (%) 19 (4) 4 (4)
Diagnosis, n (%)
Breast cancer 421 (79) 66 (83)
Prostate cancer 93 (17) 10 (13)
Colorectal cancer 21 (4) 4 (5)
Physical fatigue, MFI, mean (SD) 11.2 (4) 11.7 (4)
EORTC QLQ C30, mean (SD)
Global health status/QoL 66.3 (20.2) 70.7 (17.7)
Physical Function 88.5 (13.5) 90.0 (11.5)
MVPA, hours/day, mean (SD) 1.23 (0.8) 1.12 (0.6)
Abbreviations: BMI = Body Mass Index; MVPA = Moderate-to-vigorous intensity physical activity; QoL = Quality of
life.
Financial situation: worst = 1, best = 10. MFI, Physical fatigue: 4 = low fatigue, 20 = high fatigue. Global health status/
QoL: 0 = low quality of life, 100 = high quality of life. Physical Function: 0 = low/unhealthy level of functioning,
100 = high/healthy level of functioning. Moderate-to-vigorous intensity = physical activity at or above 3 metabolic
equivalents (METs).
https://doi.org/10.1371/journal.pone.0234507.t001
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In the intervention study there were 465 (87%) and 70 (13%) tests evaluated as “to exhaus-
tion” and “not to exhaustion”, respectively. The corresponding numbers were 76 (95%) and 4
(5%) in the cohort study. For the intervention study, _VO2peak was significantly (p<0.001)
higher in the tests evaluated as “to exhaustion” (30.3 ml/kg/min, CI: 29.6–30.9) than “not to
exhaustion” (26.6 ml/kg/min, CI: 24.9–28.3).
The percentage distribution and mean _VO2peak in subjects fulfilling and not fulfilling dif-
ferent cut-points within the criteria of _VO2 plateau, RER, predicted HR (Tanaka) and Borgs’
RPE are presented in Fig 1. Regarding the _VO2 plateau criterion, the most accessible cut-point
(D _VO2 �150 ml/min) was fulfilled by nearly all patients (91%), but mean _VO2peak was the
same as in patients who had not fulfilled this cut-point. The prevalence of fulfillment of cut-
points was reduced by being stricter (�80 [63%] and�50 ml/min [45%]), but mean _VO2peak
Fig 1. Mean (with SD) _V_O2peak stratified on fulfilling and not fulfilling criteria for _V
_O2max max in patients diagnosed with breast, prostate or colorectal cancer
(n = 535). Abbreviations: RER = Respiratory Exchange Ratio; RPE = rates of perceived exertion on Borg scale 6–20; _V_O2 = oxygen uptake; _V
_CO2 = carbon dioxide
production. Tanaka, HRmax = 208 - (0.7
�age), Plateau, D _V_O2 = a change in _V
_O2 of less than 150, 80 or 50 ml/min from one minute to the next minute.
https://doi.org/10.1371/journal.pone.0234507.g001
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was significantly higher (p<0.001 and p = 0.028, respectively) in the patients who did not fulfill
these two cut-points (Fig 1). The largest difference in _VO2peak was observed between individ-
uals who fulfilled (n = 514; 30.1 ml/kg/min) and those who did not fulfill (n = 21; 22.2 ml/kg/
min) the RER�1.0 criterion (p<0.001). Many patients fulfilled the strictest cut-point of�95%
predicted HRpeak (76%). Regarding scoring on Borg’s scale, mean _VO2peak in “fulfilled” vs
“not fulfilled” did not differ across the three cut-points.
As seen in the bivariate analysis presented in Table 3, fR peak, HRpeak, RERpeak, peak
Borg’s RPE and plateau were significantly associated with the test leader’s evaluation (adjusted
for age, diagnosis, _VO2peak and test duration). Of the four adjusting variables, test duration
was the only variable that was significantly associated to the test leader’s evaluation (p = 0.010).
In the multivariate analysis, peak values for fR, RER and Borg’s RPE remained significantly
associated with the test leader’s evaluation (Table 3). When adjusting for age, diagnosis,
_VO2peak and test duration, the probability of being categorized as “to exhaustion” was dou-
bled both for each 0.1 increase in RER (OR: 2.07, 95%CI 1.39–3.08) and for each unit increase
in Borg’s RPE (OR: 2.05, 95%CI 1.67–2.51). For each 10 breaths/min increase in fR, the proba-
bility of being categorized as “to exhaustion” was increased by 60%.
The three cut-points for these associated criteria, calculated from the ROC curves (Fig 2),
were fR�40 (true positive rate (TPR): 0.55, 95%CI 0.51–0.60), RER� 1.14 (TPR: 0.66, 95% CI
0.62–0.70) and Borg�18 (TPR: 0.71, 95% CI 0.67–0.75). The probabilities of correctly classify-
ing the test leader’s evaluations were 77% for Borg’s RPE, 73% for RER and 70% for fR. When
combining the three criteria, the predicted probability was the best (86%).
When performing the cross-validation analysis in the cohort study, three of the four (75%)
tests classified as “not to exhaustion” were correctly classified. Regarding the tests classified as
“to exhaustion” by the test leaders, 50 of the 76 tests (66%) were correctly classified. In total,
66% of the tests were correctly classified, and 34% were misclassified.
Discussion
The criteria RERpeak, Borg’s RPE and fR peak were associated with the test leader’s evaluation of
whether a test was defined as “to exhaustion”. The cut-points that could best predict the test lead-
er’s evaluation were RER�1.14, RPE�18 and fR�40. Neither the HRmax criterion, nor attaining
a _VO2 plateau at the end of the _VO2max test was associated with the test leader’s evaluation.
Table 3. Odds ratios (OR’s) from bivariate- and multivariate analysis with test-leaders’ subjective evaluation of
the _V_O2max test as the outcome variable.
Bivariate analysis Multivariate analysis
Effect variable OR’s (95% CI) p value OR’s (95% CI) p value
fR peak, breaths/min 1.12 (1.07, 1.17) <0.001 1.06 (1.01, 1.12) 0.018
HRpeak, beat/min 1.02 (1.00, 1.04) 0.017
RERpeak, _VC_O2= _V
_O2 2.21 (1.59, 3.08) <0.001 2.07 (1.39, 3.08) <0.001
Borg scale, RPE 6–20 2.04 (1.68, 2.46) <0.001 2.05 (1.67, 2.51) <0.001
Plateau, D _V_O2 �150 ml/min 2.22 (1.01, 4.87) 0.048
The coefficients are given with 95% confidence intervals. Abbreviations: CI = Confidence interval; OR’s = Odds
Ratio’s; fR = respiratory frequency; HR = heart rate; RER = Respiratory Exchange Ratio; RPE = rates of perceived
exertion; _VC_O2 = carbon dioxide production; _V
_O2 = oxygen uptake.
Adjusted for age, diagnosis, _V_O2peak and test-duration.
https://doi.org/10.1371/journal.pone.0234507.t003
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Of note, we observed that newly diagnosed cancer patients (before beginning treatment)
responded similarly to healthy age-matched individuals in peak values of _VO2, RER, Borg’s RPE
and HR, although the present results are peak values (before applying any criteria verifying
_VO2max) and the results from Edvardsen et al. were max values [51]. In addition, the cut-points
of RER and RPE found through our ROC analysis did not differ from previously used cut-points
in various populations [32, 52]. Therefore, we may assume that the cancer disease, per se, have
not affected their ability to push themselves close to their maximal effort. Hence, the findings in
the present study may be useful and transferable to other age-matched healthy individuals.
There is no “blueprint” regarding which outcome variable to apply when investigating crite-
ria to verify _VO2max. Our experimental approach, in which the test leader’s evaluation is used
for this purpose, has not been tried in this setting previously to our knowledge and is impor-
tant to have in mind when interpreting our findings. Importantly, strong efforts were made in
reducing the variation between test leaders through making the standards and protocols uni-
form for performing the tests, and all test leaders were certified by the same person who coor-
dinated and ensured the quality of this part of the Phys-Can project.
Respiratory exchange ratio
The RER�1.14 cut-point that was determined through the ROC analysis, is similar to�1.15,
which is a strict cut-point used in some studies [32], and to our knowledge, originates from
the work by Issekutz et al from the 1960s [53]. In the present study, a finding of 56%
Fig 2. A: Receiver operating characteristic curves for RER, Borg’s RPE and fR, with the test-leader’s evaluation as the outcome variable. B: Number and percentage of
patients fulfilling one, two and three of the criteria cut-points in the Phys-Can intervention study (n = 535). Abbreviations: RER = Respiratory Exchange Ratio;
ROC = receiver operating characteristic; RPE = ratings of perceived exertion; fR = respiratory frequency.
https://doi.org/10.1371/journal.pone.0234507.g002
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participants fulfilling the�1.15 criterion, was in agreement with Edvardsen and colleagues’
participants (aged 20–85 years), where 65% achieved this cut-point [37], especially when tak-
ing age into consideration. In a study of younger (mean age 37 years) overweight and obese
adults, the prevalence of achieving RER�1.15 was higher (89%) [38]. In similar treadmill pro-
tocols, RERpeak was found to decrease with age [37], and considering that our participants
had a mean age of 59 years, the mean RERpeak of 1.16 in the present study was comparable to
the mean RERpeak of 1.17 seen in participants from 50 to 64 years old in Edvardsen and col-
leagues’ study [37]. Nearly all subjects (96%) in the present study fulfilled the RER�1.0 crite-
rion and 91% reached the age-related recommended cut-point of RER�1.05 for healthy
individuals [37]. Schneider et al. (2019) [42] found percentage of fulfillment of the RER�1.1
cut-point (84%) to be similar as in the present study (77%), though slightly higher, possibly
because of using a cycle ergometer.
In healthy and clinical populations, the rationale for choosing one cut-point instead of
another seems to be lacking, and because several cut-points have been used previously, ranging
from 1.00 to 1.20 [52], the selected cut-points may have been arbitrary [35]. Explanations for
why people attain different levels of RERpeak at maximal tests are not fully understood, but
age may affect RERmax [37]. Another factor is the test protocol used. Because a more rapid
incremental work rate increases the anaerobic energy contribution, the rate of HCO3 buffering
of lactic acid-derived H+ ions is increased (i.e. the rate of CO2 output will be greater because it
follows the rate of H+ buffering) [54]. Consequently, shorter and faster test protocols result in
higher RERpeak values compared with ramp tests that are of longer durations [35]. The RER
cut-off values should therefore probably be made protocol specific.
Food intake and medication are also important factors that may affect RERpeak. It was sug-
gested that habitual dietary patterns that influence the systemic acid load may account for 19%
of the variability observed in RERpeak [55]. In women treated with chemotherapy and tamoxi-
fen-like drugs, the accumulation of lactate was less compared with healthy women, especially
at high exercise intensity (70% of _VO2max) [56]. In combination with the observed lower car-
bohydrate oxidation and greater fat oxidation, the authors suggested that the cancer itself,
and/or the medications received, may disrupt normal energy metabolism in patients with can-
cer during exercise [56]. This highlights the importance of validating these criteria in different
patient groups, and in cancer patients the validation should also be made in tests completed
during treatment.
Perceived exertion
A Borg’s RPE of�18, found in our ROC analysis, did not differ from cut-points often seen in
the literature, with observed cut-points of�17,�18 or�19 [52]. Congruent with our observa-
tions, 84% of participants in Edvardsen et al. (2014) achieved the most frequently used cut-
point of RPE�17. Despite close relationships between scores on Borg’s scale and physiological
measures of intensity, such as HR, BLa- [57], and work rate during exercise [58], the validity of
Borg’s scale as a criterion in _VO2max testing has been questioned [59]. The validity in the use
of this criterion depends on the subject’s understanding of the scale and associated verbal
descriptors, the ability to differentiate between discomfort and physiological fatigue and moti-
vation [60]. It has been proposed that physically inactive individuals not accustomed to exer-
cise until exhaustion are likely to report perceived maximal exertion before they actually reach
their true _VO2max [21]. The discrepancy between the percent of participants reaching
RPE�17 (86%; 30.2 ml/kg/min) and�18 (65%; 30.4 ml/kg/min) was large in our study, con-
gruent with no differences in _VO2peak within fulfilling the two cut-points. Consequently,
choosing an RPE�17 cut-point would probably also work well for this patient group.
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Respiratory frequency
Through the ROC analysis,�40 breaths/min was found to be the cut-point best associated
with the test leader’s evaluation. This cut-point was reached by 52% of the participants, and
these participants had a significantly (p<0.001) higher _VO2peak (32 ml/kg/min), than partici-
pants not achieving this cut-point (27 ml/kg/min). To our knowledge, fR has not been used as
a criterion verifying _VO2max in previous studies, but there are implications that fR is a poten-
tially valid measure that reflects physical effort. In two studies by Nicolo et al. [40, 61], the
authors describe why fR is a better marker of physiological strain compared with the variables
_VO2, HR and BLa
-. The nonlinear increase of fR during incremental exercise follows the level
of acidosis from lactate production and is not affected by muscle damage or glycogen deple-
tion, suggesting that physical effort is more causally linked with fR than BLa-. In addition, fR is
closely related to RPE in fit males (20±3 years) and does not seem to be affected by choice of
test protocol [61]. Whether fR is a valid criterion to apply as part of verifying _VO2max needs to
be investigated in future studies.
Age predicted maximal heart rate
The age predicted HRmax was not significantly associated to the test leader’s evaluation of
whether the test was performed “to exhaustion”. In _VO2max tests performed in different pop-
ulations, fulfillment of various cut-points representing percentages of age predicted HRmax
are often seen [39, 62]. Because of 10- to 12-beats-per-minute variations in HRmax in healthy
individuals, even when taking age into account [63, 64], predicting HRmax is problematic [65,
66], and is likely to underestimate or overestimate HRmax on an individual level. A potentially
greater variation is added in patients with cancer owing to the documented impact certain can-
cer treatments have on cardiac function [67], which is commonly observed as increased HR
[68]. In addition, on the basis of the possible positive effects of beta-blockers (which cause
lower HR or a “ceiling” in HR) in relation to cancer prognosis [69], such medications also con-
tribute to complicating the use of this criterion. Taking these factors together, the age pre-
dicted HRmax is presumably a problematic criterion to apply in both healthy individuals [22,
39] and in patients with cancer, before, during and after cancer treatment.
Plateau in oxygen uptake
Finding as many as 91% to achieve the�150 ml/min plateau cut-point may be interpreted as a
positive finding. However, the mean _VO2peak was the same as in the patients that did not ful-
fill this cut-point. Whether or not�150 ml/min plateau cut-point fits the participants and pro-
tocol in the present study, could be discussed. The modified Balke protocol involves very small
_VO2-increments from one stage to the next, and therefor seems the most suitable for the 150
ml/min cut-point, compared to the other two cut-points applied in the present study. A pla-
teau in _VO2 stands out as the most widely used criterion for verifying _VO2max [23], but some
authors doubt that such a physiological plateau exists [30]. Others argue that a _VO2 plateau
exists, but the methodology used to identify it is central for detecting it [36]. The type of test
protocol and sampling acquisition may affect the observation of a plateau [31, 32], in addition
to age and fitness [23], although other studies do not agree on this [33]. Although researchers
do not agree on the rationale, undoubtedly there are huge variations in the number of subjects
fulfilling the plateau criterion in different studies [32]. Based on all considerations, questions
are raised regarding the validity of using the plateau criterion verifying true _VO2max [70] and
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other researchers have concluded that the _VO2 plateau is not a reliable physiological marker
for maximal effort in all subjects [71].
Strengths
In a large sample of patients newly diagnosed with cancer, we have managed to elucidate crite-
ria for validating _VO2max tests differently from what has been previously seen in the literature.
Thorough and consistent instructions and follow-up of the test leaders enabled conditions to
be as similar as practically possible for all participants, independent of when or where they per-
formed their _VO2max tests. The test leaders were also generally experienced with exercise test-
ing and/or with the clinical populations before the start of the Phys-Can. By including fR in
our analyses, we have started to explore another possible variable as a new criterion or norma-
tive to apply in validation of _VO2max tests.
Limitations
Few patients with colorectal cancer were included, so generalization to this or other nonin-
cluded types of cancer are questionable. Furthermore, because there were only 4 of 80 (5%)
_VO2max tests evaluated as “not to exhaustion” in the cohort study, our cross-validation was
more of a descriptive approach. The O2 analyzers were from different producers across the
three sites, and this may be a source of bias between the tests performed in Lund, Linköping
and Uppsala. For practical reasons, validity tests were, unfortunately, not performed between
the various O2 analyzers. Measurements of BLa
- were not taken after the _VO2max tests in the
Phys-Can study. Although the RER value correlates highly with BLa- [72], a measure of BLa-
would have expanded the number of objective criteria assessed. In addition, high inter-subject
variability (from 5 to 17 mM) in post-exercise lactate has been reported [73] and is, accord-
ingly, another criterion that is difficult to standardize [35]. The definition of a _VO2 plateau, as
included in the present study, is perhaps not the most suitable method because of the proto-
col-differences between the discontinuous test protocols applied on healthy young men in the
1950s by Taylor et al. and the modified Balke protocol used in Phys-Can. In addition, we did
not incorporate relative body mass into the equation. The validity of the results from the cross-
validation, where a correct classification of “to exhaustion” were made in only 66% of cases
from the cohort study, when applying the best three criteria can be questioned. However, the
low number of tests classified as “not to exhaustion” in the cohort study makes the data figures
too small to conclude anything related to how well the criteria fits another comparable sample
of individuals. Last, in the present study we did not include a verification bout directly after
each of the _VO2max tests, which potentially could have been a better approach than the test-
leaders evaluation as the effect variable when investigating the different criteria and their cut-
points.
Conclusions and future perspectives
Relating the findings to clinical practice, we suggest avoiding the predicted HRmax criterion.
On the basis of the observations in the present study, in addition to the complexity of detecting
a _VO2 plateau when using different methodologies (e.g. test protocols and data acquisition)
[23], we suggest not placing emphasis on this criterion either. We recommend a focus on RER
(in the range between�1.1 and�1.15) and RPE (�17 or�18) in addition to the test leader’s
evaluation. Also, a fR peak of�40 breaths/min may be an additional cut-point to help the test
leader evaluate the degree of exhaustion, but more research is needed to determine whether
this should be used as a criterion.
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A course for future investigations may be to determine whether the fR variable could be
part of the criteria verifying _VO2max. In addition, it would be interesting to precede with com-
parable methodologic approaches as in Schneider et al. (2019) [42], where a supramaximal ver-
ification bout was performed after the _VO2max test, in order to validate the initial _VO2max
results, only apply the method using treadmill [20]. Also, a submaximal verification phase [36]
which probably is more feasible for cancer patients, would be interesting to apply and investi-
gate further. Whether achievement of the same _VO2max value in the verification bout is a
valid criterion could be investigated together with the results from the present study, in
patients in different phases of their cancer disease. In a recent study by Santa Mina et al.
(2020), the authors describe their lab-experiences from testing 44 patients with cancer, in
which only 14% achieved all of their _VO2max criteria, and none reached a _VO2 plateau [74].
Hence, it is also important to investigate criteria for verifying _VO2max in patients that are
undergoing or have finished cancer treatment, as these patients may have other responses and
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